Forbes: Here’s Why Ozempic And Mounjaro Rivals Won’t Topple Drugmakers Novo Nordisk And Eli Lilly Anytime Soon
Additional Content
Reuters: Brokerage Charles Schwab’s long-time CEO Bettinger to retire
City AM: London readies for Raspberry Pi’s first results as a public company
The FT: How Netflix won the streaming wars
Boeing strike is a big blow, but it has bigger challenges to face: Peter McNally
BNN Bloomberg: Outlook on aviation sector
Yahoo Finance: Adobe is seeing a ‘narrative shift’: Analyst’s bullish take
CNBC: It’s hard for Boeing to reclaim share from Airbus until it sorts out its issues: Analyst
BNN Bloomberg: Broadcom sees FY sales from AI of $12B
